These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 20019600)

  • 41. Pulmonary vascular disease and exercise hemodynamics in chronic liver disease.
    Douschan P; Kovacs G; Sassmann T; Stadlbauer V; Avian A; Foris V; Tatscher E; Durchschein F; Rainer F; Spindelboeck W; Wagner M; Kniepeiss D; Zollner G; Bachmaier G; Fickert P; Olschewski H; Stauber RE
    Respir Med; 2022 Oct; 202():106987. PubMed ID: 36115317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hepatopulmonary syndrome].
    Thevenot T; Pastor CM; Cervoni JP; Jacquelinet C; Nguyen-Khac E; Richou C; Heyd B; Vanlemmens C; Mantion G; Di Martino V; Cadranel J
    Gastroenterol Clin Biol; 2009; 33(6-7):565-79. PubMed ID: 19481392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pulmonary Complications in Patients with Liver Cirrhosis].
    Han SK; Baik SK; Kim MY
    Korean J Gastroenterol; 2023 Nov; 82(5):213-223. PubMed ID: 37997217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatopulmonary syndrome and portopulmonary hypertension.
    Restrepo R; Singer EF; Baram M; Restrepo R; Singer EF; Baram M
    Hosp Pract (1995); 2013 Apr; 41(2):62-71. PubMed ID: 23680738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation.
    Krowka MJ
    Clin Chest Med; 2005 Dec; 26(4):587-97, vi. PubMed ID: 16263398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Respiratory functional impairment in patients with liver cirrhosis].
    Siemieniako A; Łapiński TW; Flisiak R
    Pol Merkur Lekarski; 2010 Apr; 28(166):319-22. PubMed ID: 20491346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension.
    Krowka MJ; Fallon MB; Kawut SM; Fuhrmann V; Heimbach JK; Ramsay MA; Sitbon O; Sokol RJ
    Transplantation; 2016 Jul; 100(7):1440-52. PubMed ID: 27326810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Portopulmonary hypertension.
    Golbin JM; Krowka MJ
    Clin Chest Med; 2007 Mar; 28(1):203-18, ix. PubMed ID: 17338936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Refractory hypoxemia during liver cirrhosis. Hepatopulmonary syndrome or "primary" pulmonary hypertension?
    Raffy O; Sleiman C; Vachiery F; Mal H; Roue C; Hadengue A; Jebrak G; Fournier M; Pariente R
    Am J Respir Crit Care Med; 1996 Mar; 153(3):1169-71. PubMed ID: 8630562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulmonary manifestations of liver diseases.
    Yeshua H; Blendis LM; Oren R
    Semin Cardiothorac Vasc Anesth; 2009 Mar; 13(1):60-9. PubMed ID: 19336439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Onset ages of hepatopulmonary syndrome and pulmonary hypertension in patients with biliary atresia.
    Ueno T; Saka R; Takama Y; Yamanaka H; Tazuke Y; Bessho K; Okuyama H
    Pediatr Surg Int; 2017 Oct; 33(10):1053-1057. PubMed ID: 28871319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum Oxidative/anti-oxidative Stress Balance Is Dysregulated in Potentially Pulmonary Hypertensive Patients with Liver Cirrhosis: A Case Control Study.
    Terao M; Takaki A; Maruyama T; Oe H; Yasunaka T; Tamaki N; Nakamura K; Tomofuji T; Yagi T; Sadamori H; Umeda Y; Shinoura S; Yoshida R; Nouso K; Ekuni D; Koike K; Ikeda F; Shiraha H; Morita M; Ito H; Fujiwara T; Yamamoto K
    Intern Med; 2015; 54(22):2815-26. PubMed ID: 26567993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peri-operative respiratory failure in a cirrhotic patient: a misleading diagnosis.
    Busani S; Rinaldi L; Barbieri E; Drago A; Barbieri A; Girardis M
    Anaesthesia; 2007 Sep; 62(9):963-5. PubMed ID: 17697229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Shortness of breath due to portopulmonary hypertension and hepatopulmonary syndrome: diagnostic challenges and complex management approach in frail patients.
    Zafar M; Patel A; Ashraf M; Tibble J
    Clin Med (Lond); 2022 Sep; 22(5):485-489. PubMed ID: 36507807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver in cardiopulmonary disease.
    Polavarapu N; Tripathi D
    Best Pract Res Clin Gastroenterol; 2013 Aug; 27(4):497-512. PubMed ID: 24090938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatopulmonary syndrome - past to present.
    Varghese J; Ilias-basha H; Dhanasekaran R; Singh S; Venkataraman J
    Ann Hepatol; 2007; 6(3):135-42. PubMed ID: 17786138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evolving dilemmas and management of portopulmonary hypertension.
    Krowka MJ
    Semin Liver Dis; 2006 Aug; 26(3):265-72. PubMed ID: 16850376
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Portopulmonary hypertension and hepatopulmonary syndrome.
    Hoeper MM; Krowka MJ; Strassburg CP
    Lancet; 2004 May; 363(9419):1461-8. PubMed ID: 15121411
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatopulmonary Syndrome and Portopulmonary Hypertension: Current Status and Implications for Liver Transplantation.
    Weinfurtner K; Forde K
    Curr Hepatol Rep; 2020 Sep; 19(3):174-185. PubMed ID: 32905452
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Macitentan treatment of portopulmonary hypertension with hepatopulmonary syndrome: a case report and literature review.
    Li N; Wu Q; Meng J; Feng C; Jiang S; Chen M; Xu W; Wang F; Zhang Y; Liu J; Xu C; Liu G; Gao H
    ESC Heart Fail; 2023 Aug; 10(4):2718-2721. PubMed ID: 37313579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.